UDR Readies to Report Q4 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2218835/udr-readies-to-report-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2218835
Jan 31, 2024 - UDR's Q4 earnings are likely to have gained from portfolio diversification and technological initiatives, though high supply and elevated interest rates are likely to have acted as dampeners.
0
What's in Store for Equity Residential (EQR) in Q4 Earnings?
https://www.zacks.com/stock/news/2217265/what-s-in-store-for-equity-residential-eqr-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217265
Jan 29, 2024 - Equity Residential's (EQR) Q4 results are likely to benefit from its portfolio diversification efforts and technology investments, though high supply is likely to have played a spoilsport.
0
JEPI Doesn't Fare Well In Rising Markets
https://seekingalpha.com/article/4665571-jepi-doesnt-fare-well-in-rising-markets?source=feed_tag_etf_portfolio_strategy
Jan 27, 2024 - Earlier last year, I thought JEPI was a good ETF option compared to SCHD, and this view mostly played out. But read why I have a more bearish outlook on JEPI now.
0
RVT: 8% Yield From A Well-Structured Small-Cap Fund
https://seekingalpha.com/article/4665562-rvt-8-percent-yield-from-a-well-structured-small-cap-fund?source=feed_tag_etf_portfolio_strategy
Jan 27, 2024 - RVT has a diversified portfolio of 393 companies, with a higher skew towards industrials, technology, and materials. Check out why I'm bullish on RVT CEF.
0
Zenbivy Bed Sleeping Bag and Quilt Review: Sleep Well Wherever You Go
https://www.wired.com/review/zenbivy-sleeping-bag-quilt-system/
Jan 26, 2024 - Zenbivy’s clever quilt-and-sheet sleeping bag alternative provided the best backcountry sleep I’ve ever had.
0
Key Factors to Impact Boston Properties' (BXP) Q4 Earnings
https://www.zacks.com/stock/news/2215938/key-factors-to-impact-boston-properties-bxp-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2215938
Jan 25, 2024 - Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q4 earnings. However, higher interest expenses might have hurt the company.
0
Tribes accused of predatory lending, and some may have been fleeced as well
https://www.startribune.com/minnesota-attorney-general-predatory-lending-montana-fort-belknap-lac-courtes-oreilles/600338435/
Jan 25, 2024 - Attorney General Keith Ellison's lawsuits against Montana tribe and others reveal how complicated tribal online lending operations are.
0
Vital Energy: Well Performance Continues To Exceed Expectations
https://seekingalpha.com/article/4664845-vital-energy-well-performance-continues-to-exceed-expectations?source=feed_all_articles
Jan 24, 2024 - Vital Energy continued to report strong production results with Q4 2023 total production exceeding expectations. Find out why VTLE stock is a Buy.
0
U.S. Stocks Pull Back Well Off Highs As Treasury Yields Rebound
https://www.rttnews.com/story.aspx?Id=3418894
Jan 24, 2024 - Stocks showed a strong move to the upside in early trading on Wednesday but gave back ground over the course of the session. The major averages pulled back well off their highs of the session in afternoon trading, with the Dow sliding into negative territory. Despite the afternoon pullback, the S&P 500 crept up to a new record closing high.
0
Johnson & Johnson’s MedTech performance augurs well for industry: analysts
https://seekingalpha.com/news/4057471-johnson--johnsons-medtech-beat-augurs-well-industry?source=feed_sector_healthcare
Jan 23, 2024 - Johnson & Johnson (JNJ) stock drops even after the comnany beat forecasts with its Q4 2023 results while analysts saw positives in its MedTech unit. Read more here.
0